摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

乙基(4-氟-1-萘基)(氧代)乙酸酯 | 409081-83-0

中文名称
乙基(4-氟-1-萘基)(氧代)乙酸酯
中文别名
——
英文名称
ethyl 4-fluoro-α-oxo-1-naphthaleneacetate
英文别名
ethyl 2-(4-fluoronaphthyl)-2-oxoacetate;Ethyl 4-fluoro-1-naphthoylformate;ethyl 2-(4-fluoronaphthalen-1-yl)-2-oxoacetate
乙基(4-氟-1-萘基)(氧代)乙酸酯化学式
CAS
409081-83-0
化学式
C14H11FO3
mdl
MFCD09801427
分子量
246.238
InChiKey
PSBJHMISSXOZTN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    377.0±25.0 °C(Predicted)
  • 密度:
    1.257±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:e43f1b68d2363a1abe54481d6f06d0ef
查看

反应信息

  • 作为反应物:
    描述:
    乙基(4-氟-1-萘基)(氧代)乙酸酯 在 sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以15 g的产率得到4-fluoro-α-oxo-1-naphthaleneacetic acid
    参考文献:
    名称:
    TW2017/22917
    摘要:
    公开号:
  • 作为产物:
    描述:
    1-溴-4-氟萘草酸二乙酯盐酸正丁基锂 作用下, 以 四氢呋喃乙酸乙酯 为溶剂, 以76%的产率得到乙基(4-氟-1-萘基)(氧代)乙酸酯
    参考文献:
    名称:
    Aminopyridinyl-, aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors
    摘要:
    苯乙酰胺化合物的描述,包括式I的化合物: 或其溶剂化物、水合物或药学上可接受的盐;其中R 3 -R 6 ,R 11 ,B,Y和W在规范中列出。本发明的化合物是蛋白酶的强效抑制剂,特别是类似胰蛋白酶的丝氨酸蛋白酶,如凝血酶和Xa因子。描述了用于抑制血小板丢失、抑制血小板聚集物形成、抑制纤维蛋白形成、抑制血栓形成和抑制栓塞形成的组合物。本发明化合物的其他用途是作为抗凝剂,嵌入或物理连接到用于制造用于血液采集、血液循环和血液储存的设备中的材料,如导管、血液透析机、血液采集注射器和管、血管和支架。此外,这些化合物可以被检测标记并用于体内血栓的成像。
    公开号:
    US20020061872A1
点击查看最新优质反应信息

文献信息

  • Aminopyridyl-substituted phenyl acetamides as protease inhibitors
    申请人:3-Dimensional Pharmaceuticals, Inc.
    公开号:US20030073833A1
    公开(公告)日:2003-04-17
    Phenyl acetamide compounds are described, including compounds of Formula I: 1 or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R 3 -R 6 , R 11 , B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.
    描述了苯乙酰胺化合物,包括公式I的化合物:1或其溶剂化物、合物或药学上可接受的盐;其中R3-R6、R11、B、Y和W在规范中列出。本发明的化合物是蛋白酶的有效抑制剂,特别是类似胰蛋白酶丝氨酸蛋白酶,如凝血酶和第Xa因子。描述了抑制血小板丢失、抑制血小板聚集形成、抑制纤维蛋白形成、抑制血栓形成和抑制栓塞形成的组合物。本发明化合物的其他用途是作为抗凝剂嵌入或物理连接到用于血液采集、血液循环和血液储存的器械的制造材料中,例如导管、血液透析机、血液采集注射器和管道、血液管路和支架。此外,这些化合物可以被标记并用于体内血栓的成像。
  • Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors
    申请人:Pan Wenxi
    公开号:US20050159457A1
    公开(公告)日:2005-07-21
    Phenyl acetamide compounds are described, including compounds of Formula I: or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R 3 -R 6 , R 11 , B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.
    本文描述了苯乙酰胺化合物,包括式I的化合物:或其溶剂化物、合物或药学上可接受的盐;其中R3-R6、R11、B、Y和W在说明书中列出。该发明的化合物是蛋白酶的强效抑制剂,特别是类似胰蛋白酶丝氨酸蛋白酶,如凝血酶和Xa因子。描述了用于抑制血小板丢失、抑制血小板聚集形成、抑制纤维蛋白形成、抑制血栓形成和抑制栓子形成的组合物。本发明化合物的其他用途是作为抗凝剂嵌入或物理连接到用于血液收集、血液循环和血液储存的器械制造中使用的材料中,例如导管、血液透析机、血液采集注射器和管道、血液管路和支架。此外,这些化合物可以被标记并用于体内血栓的成像。
  • Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors
    申请人:3-Dimensional Pharmaceuticals, Inc.
    公开号:US06521663B2
    公开(公告)日:2003-02-18
    Phenyl acetamide compounds are described, including compounds of Formula I: or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R3-R6, R11, B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.
    本文描述了苯乙酰胺化合物,包括式I的化合物:或其溶剂化物,合物或药学上可接受的盐;其中R3-R6,R11,B,Y和W在说明书中列出。该发明的化合物是蛋白酶的强效抑制剂,特别是类似胰蛋白酶丝氨酸蛋白酶,如凝血酶和Xa因子。本文还描述了用于抑制血小板丢失,抑制血小板聚集形成,抑制纤维蛋白形成,抑制血栓形成和抑制栓子形成的组合物。发明的化合物的其他用途是作为抗凝剂嵌入或物理连接到用于血液采集,血液循环和血液储存的设备中使用的材料中,例如导管,血液透析机,血液采集注射器和管道,血液管路和支架。此外,该化合物可以被标记并用于体内血栓的成像。
  • AMINOPYRIDINYL-, AMINOGUANIDINYL- AND ALKOXYGUANIDINYL- SUBSTITUTED PHENYL ACETAMIDES AS PROTEASE INHIBITORS
    申请人:3-DIMENSIONAL PHARMACEUTICALS, INC.
    公开号:EP1324981A2
    公开(公告)日:2003-07-09
  • US6521663B2
    申请人:——
    公开号:US6521663B2
    公开(公告)日:2003-02-18
查看更多